Design of soluble conjugates of biodegradable polymeric carriers and adriamycin
暂无分享,去创建一个
J. Feijen | P. Boon | F. Kaspersen | C. Hoes | E. Bos | F. Kaspersen
[1] J. Feijen,et al. Synthesis and biodistribution of immunoconjugates of a human IgM and polymeric drug carriers , 1992 .
[2] K. Ulbrich,et al. Polymers containing enzymatically degradable bonds, XII. Effect of spacer structure on the rate of release of daunomycin and adriamycin from poly [N-(2-hydroxypropyl)-methacrylamide] copolymer drag carriers in vitro and antitumour activity measured in vivo , 1992 .
[3] J. Feijen,et al. Association of macromolecular prodrugs consisting of adriamycin bound to poly (L-glutamic acid) , 1991 .
[4] P. Boon,et al. Passive immunotherapy of cancer: perspectives and problems , 1991 .
[5] J. Feijen,et al. OPTIMIZATION OF MACROMOLECULAR PRODRUGS OF THE ANTITUMOR ANTIBIOTIC ADRIAMYCIN , 1985 .
[6] J. Feijen,et al. The synthesis and characterization of polypeptide-adriamycin conjugates and its complexes with adriamycin. Part I , 1985 .
[7] Y. Takeda,et al. A novel method of conjugation of daunomycin with antibody with a poly-L-glutamic acid derivative as intermediate drug carrier. An anti-alpha-fetoprotein antibody-daunomycin conjugate. , 1984, Journal of medicinal chemistry.
[8] K. Ulbrich,et al. Effect of the chemical structure of N- (2- hydroxypropyl) methacrylajnide copolymers on their ability to induce antibody formation in inbred strains of mice , 1984 .
[9] J. Feijen,et al. Synthesis, Characterization and Antitumor Activity of Macromolecular Prodrugs of Adriamycin , 1984 .
[10] T. A. Connors. Alkylating Prodrugs in Cancer Chemotherapy , 1983 .
[11] W. Shen,et al. cis-Aconityl spacer between daunomycin and macromolecular carriers: a model of pH-sensitive linkage releasing drug from a lysosomotropic conjugate. , 1981, Biochemical and biophysical research communications.
[12] M. Sela,et al. Immunological studies with synthetic polypeptides. , 1966, Advances in immunology.